NCT01644149View on ClinicalTrials.gov

Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Influenza Prophylaxis
Interventions
DEVICE

Stratis Jet Injector

Intramuscular administration of 0.5 mL of 2011-2012 Fluzone trivalent inactivated influenza vaccine

DEVICE

Needle and Syringe

Intramuscular administration of 0.5 mL of 2011-2012 Fluzone trivalent inactivated influenza vaccine

BIOLOGICAL

2011-2012 Fluzone trivalent inactivated influenza vaccine

Trial Locations (1)

80247

Bel-Rea Institute, Denver

Sponsors

Lead Sponsor

PharmaJet, Inc.
All Listed Sponsors
lead

PharmaJet, Inc.

INDUSTRY

NCT01644149 - Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe | Biotech Hunter | Biotech Hunter